Amrize Ltd (NYSE:AMRZ) Receives $60.75 Average Target Price from Analysts

Amrize Ltd (NYSE:AMRZ) has received a consensus recommendation of “Moderate Buy” from the fifteen analysts that are presently covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $60.75.

AMRZ has been the topic of several research reports. Royal Bank Of Canada lowered Amrize from an “outperform” rating to a “sector perform” rating and raised their price objective for the stock from $56.00 to $60.00 in a report on Monday, December 8th. Oddo Bhf started coverage on shares of Amrize in a research note on Monday, November 3rd. They set a “neutral” rating for the company. Kepler Capital Markets upgraded Amrize to a “strong-buy” rating in a research note on Tuesday, October 21st. Citigroup boosted their price target on Amrize from $63.00 to $67.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. Finally, Stephens started coverage on shares of Amrize in a report on Friday, November 14th. They set an “overweight” rating and a $60.00 price target on the stock.

Amrize Stock Performance

Amrize stock opened at $58.95 on Monday. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.45 and a quick ratio of 0.97. The stock has a market cap of $32.60 billion and a price-to-earnings ratio of 32.04. The firm has a 50 day simple moving average of $55.19 and a 200-day simple moving average of $52.03. Amrize has a 1-year low of $44.12 and a 1-year high of $60.57.

Insider Transactions at Amrize

In other news, Director Nicholas C. Gangestad bought 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 19th. The stock was acquired at an average price of $47.34 per share, for a total transaction of $94,680.00. Following the transaction, the director directly owned 4,958 shares of the company’s stock, valued at $234,711.72. This trade represents a 67.61% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link.

Institutional Investors Weigh In On Amrize

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Next Capital Management LLC bought a new stake in shares of Amrize in the 4th quarter valued at about $203,000. LPL Financial LLC lifted its holdings in shares of Amrize by 325.7% during the 4th quarter. LPL Financial LLC now owns 38,261 shares of the company’s stock valued at $2,069,000 after purchasing an additional 29,273 shares in the last quarter. Franklin Resources Inc. raised its holdings in shares of Amrize by 60.2% during the fourth quarter. Franklin Resources Inc. now owns 97,142 shares of the company’s stock worth $5,278,000 after acquiring an additional 36,519 shares during the period. JPMorgan Chase & Co. lifted its position in Amrize by 23.1% in the 4th quarter. JPMorgan Chase & Co. now owns 3,683,942 shares of the company’s stock valued at $199,228,000 after acquiring an additional 691,747 shares in the last quarter. Finally, Clearbridge Investments LLC boosted its stake in Amrize by 0.5% in the 4th quarter. Clearbridge Investments LLC now owns 180,516 shares of the company’s stock worth $9,762,000 after purchasing an additional 949 shares during the period.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.